{"id":15281,"date":"2012-08-31T10:30:00","date_gmt":"2012-08-31T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/redazionale\/"},"modified":"2012-08-31T10:30:00","modified_gmt":"2012-08-31T08:30:00","slug":"redazionale","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/redazionale\/","title":{"rendered":"EDITORIAL"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: right; margin: 0cm 0cm 10pt\">&nbsp;<img decoding=\"async\" id=\"rg_hi\" class=\"rg_hi uh_hi\" alt=\"\" data-height=\"73\" data-width=\"85\" style=\"width: 85px; height: 73px\" src=\"https:\/\/encrypted-tbn1.google.com\/images?q=tbn:ANd9GcQTH5MJpT_B5ofSYzMLW7y7IXesUrtJ8SHyY7M8sp8g8VTAbUEvWQ\" \/><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold; mso-font-kerning: 18.0pt\">La SIF, Societ&agrave; Italiana di Farmacologia, nella sua &ldquo;Position Paper&rdquo; (<\/span><span style=\"line-height: 115%; font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: #555555; font-size: 14pt\"><a href=\"http:\/\/www.sifweb.org\/docs\/sif_position_paper_farmaci_equivalenti_ott2010.php\" target=\"_blank\" rel=\"noopener\"><b><span style=\"color: #c86000; text-decoration: none; text-underline: none\">Equivalent drugs<\/span><\/b><\/a><\/span><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold; mso-font-kerning: 18.0pt\">) dell&rsquo;ottobre 2010, riporta la tabella in cui si elencano i casi di trattamenti farmacologici inefficaci (assenza di risposta terapeutica) segnalati all&rsquo;AIFA.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold; mso-font-kerning: 18.0pt\">Da essa si desume:<\/p>\n<p><\/span><\/p>\n<p class=\"MsoListParagraphCxSpFirst\" style=\"text-align: left; text-indent: -18pt; margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: Arial\"><span style=\"mso-list: Ignore\">&#8211;<span style=\"font: 7pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><\/span><\/span><span style=\"line-height: 115%; font-size: 14pt\"><font face=\"Calibri\">N&deg; totale di segnalazioni per inefficacia:<span style=\"mso-spacerun: yes\">&nbsp;&nbsp; <\/span><span style=\"mso-spacerun: yes\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span>75<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoListParagraphCxSpMiddle\" style=\"text-align: left; text-indent: -18pt; margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: Arial\"><span style=\"mso-list: Ignore\">&#8211;<span style=\"font: 7pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><\/span><\/span><span style=\"line-height: 115%; font-size: 14pt\"><font face=\"Calibri\">N&deg; di segnalazioni per prodotto di marca:<span style=\"mso-spacerun: yes\">&nbsp; <\/span><span style=\"mso-spacerun: yes\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><span style=\"mso-spacerun: yes\">&nbsp;<\/span>3 <span style=\"mso-spacerun: yes\">&nbsp;&nbsp;&nbsp;&nbsp;<\/span>(4%)<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoListParagraphCxSpLast\" style=\"text-align: left; text-indent: -18pt; margin: 0cm 0cm 10pt 36pt; mso-list: l0 level1 lfo1\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 14pt; mso-fareast-font-family: Arial\"><span style=\"mso-list: Ignore\">&#8211;<span style=\"font: 7pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><\/span><\/span><span style=\"line-height: 115%; font-size: 14pt\"><font face=\"Calibri\">N&deg; di segnalazioni per prodotto equivalente: 72<span style=\"mso-spacerun: yes\">&nbsp; <\/span><b style=\"mso-bidi-font-weight: normal\"><span style=\"color: #c00000\">(96%)<\/span><\/b><\/font><\/p>\n<p><\/span><\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; La SIF, Societ&agrave; Italiana di Farmacologia, nella sua &ldquo;Position Paper&rdquo; (Farmaci Equivalenti) dell&rsquo;ottobre 2010, riporta la tabella in cui si elencano i casi di trattamenti farmacologici inefficaci (assenza di risposta terapeutica) segnalati all&rsquo;AIFA. Da essa si desume: &#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N&deg; totale di segnalazioni per inefficacia:&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75 &#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N&deg; di segnalazioni per prodotto di marca:&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15281"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15281\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}